Multislice tomography to stratify low-risk chest pain. Lower cost and larger revascularization. 

Original title: Outcomes After Coronary Computed Tomography Angiography in the Emergency Department. A Systematic Review and Meta-Analysis of Randomized, Controlled Trials. Reference: Edward Hulten et al. J Am Coll Cardiol 2013. Article in press

Chest pain is the second most common cause for visiting an emergency department. In all consultations, only few are finally acute coronary syndromes, for this purpose several strategies have been tested to improve efficiency and reduce costs. Most centres choose to hospitalize patients or send them to a pain unit which prevents inadvertent discharge of a patient having an acute coronary syndrome, this choice consume and extend stay and increases costs.

The aim of this meta-analysis was to evaluate randomized studies comparing the use of multislice computed tomography coronary angiography versus standard strategy for the stratification risk of chest pain in the emergency department. We analysed four randomized studies with a total of 3266 patients (1869 patients in CT branch and 1397 standard strategy) consulting for low-risk chest pain (ECG with out ischemic changes and negative biomarkers). Baseline characteristics were similar between groups.

CT branch patients were more frequently refer to catheterization (8.4% versus 6.3%, p = 0.030) and received revascularization more frequently either by angioplasty or surgery (4.6% versus 2.6%, p = 0.004). The absolute increase was 21 diagnostic catheterizations and 20 revascularization procedures per 1000 patients. All studies reported a significant decrease of hospital stay and costs with the use of CT.

Conclusion: 

Stratification of low-risk chest pain in the emergency department with multislice CT was safe, reducing costs and hospital stay. Was associated with an increased incidence of catheterizations and revascularization compared with the standard strategy.

Commentary:

Low event rate in both groups (no deaths and few strokes) prevents to take conclusions on clinical end points. It will take many more large studies, given the low risk of the population, to see if CT scan and subsequent greater revascularization, decrease events. Beyond the foregoing, the fact of being a safe strategy and show a lower cost justifies its use.

SOLACI.ORG

More articles by this author

Radial Patency in Coronary Procedures: Is Heparin Enough or Should We Aim for Distal Transradial Access?

Transradial access is the preferred route in most coronary procedures due to its proven reduction in mortality compared to transfemoral access. However, one of...

iFR- vs. FFR-Guided Coronary Revascularization: 5-Year Clinical Outcomes

The assessment of coronary stenosis using coronary physiology has become a key tool in guiding revascularization. The two most widely used techniques are fractional...

Patients at High Risk of Bleeding After Coronary Angioplasty: Are Risk Assessment Tools ARC-HBR and PRECISE-DAPT Useful?

Patients undergoing coronary stenting typically receive dual antiplatelet therapy (DAPT) for 6 to 12 months, consisting of a P2Y12 receptor inhibitor and aspirin. While DAPT...

ACC 2025 | WARRIOR: Ischemia in Women with Non-Obstructive Coronary Artery Disease

Approximately half of all women with symptomatic ischemia who undergo coronary angiography are found to have non-obstructive coronary artery disease ((ischemia and non-obstructive coronary...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Pretreatment with DAPT in Acute Coronary Syndrome: An Ongoing Debate?

In acute coronary syndrome (ACS) dual antiplatelet therapy (DAPT) has become a fundamental pillar after percutaneous coronary intervention (PCI), preventing stent thrombosis and acute...

Measuring Post-TAVI Gradients and Their Implications: Are Invasive and Echocardiographic Assessments Comparable?

Transcatheter aortic valve implantation (TAVI) is considered the treatment of choice for a significant proportion of patients with symptomatic aortic stenosis. Outcomes have improved...

Another Blow for Intra-Aortic Balloon Pumo Counterpulsation? Randomized Study on Its Use in Chronic Heart Failure Progressing to Cardiogenic Shock

Cardiogenic shock (CS) remains a condition with extremely high mortality (around 50%). While most therapies for this pathology have been studied in CS secondary...